Howe & Rusling’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-100
| Closed | -$1K | – | 957 |
|
|
2022
Q3 | $1K | Buy |
+100
| New | +$1K | ﹤0.01% | 1012 |
|
|
2018
Q4 | – | Sell |
-704
| Closed | -$15K | – | 894 |
|
|
2018
Q3 | $15K | Buy |
+704
| New | +$15K | ﹤0.01% | 438 |
|
|
2018
Q1 | – | Sell |
-55
| Closed | -$1K | – | 1002 |
|
|
2017
Q4 | $1K | Sell |
55
-2,042
| -97% | -$37.1K | ﹤0.01% | 803 |
|
|
2017
Q3 | $37K | Sell |
2,097
-501
| -19% | -$8.84K | 0.01% | 330 |
|
|
2017
Q2 | $86K | Hold |
2,598
| – | – | 0.02% | 218 |
|
|
2017
Q1 | $83K | Buy |
2,598
+1,937
| +293% | +$61.9K | 0.02% | 215 |
|
|
2016
Q4 | $24K | Sell |
661
-2,396
| -78% | -$87K | 0.01% | 339 |
|
|
2016
Q3 | $141K | Buy |
3,057
+129
| +4% | +$5.95K | 0.03% | 166 |
|
|
2016
Q2 | $147K | Sell |
2,928
-300
| -9% | -$15.1K | 0.03% | 154 |
|
|
2016
Q1 | $173K | Buy |
3,228
+565
| +21% | +$30.3K | 0.04% | 150 |
|
|
2015
Q4 | $175K | Sell |
2,663
-187
| -7% | -$12.3K | 0.04% | 155 |
|
|
2015
Q3 | $161K | Sell |
2,850
-432
| -13% | -$24.4K | 0.04% | 167 |
|
|
2015
Q2 | $194K | Hold |
3,282
| – | – | 0.04% | 163 |
|
|
2015
Q1 | $204K | Buy |
3,282
+267
| +9% | +$16.6K | 0.05% | 156 |
|
|
2014
Q4 | $173K | Hold |
3,015
| – | – | 0.04% | 156 |
|
|
2014
Q3 | $162K | Sell |
3,015
-63
| -2% | -$3.39K | 0.04% | 154 |
|
|
2014
Q2 | $161K | Buy |
3,078
+105
| +4% | +$5.49K | 0.04% | 166 |
|
|
2014
Q1 | $157K | Buy |
2,973
+910
| +44% | +$48.1K | 0.04% | 164 |
|
|
2013
Q4 | $83K | Sell |
2,063
-1,071
| -34% | -$43.1K | 0.02% | 230 |
|
|
2013
Q3 | $119K | Buy |
3,134
+188
| +6% | +$7.14K | 0.04% | 182 |
|
|
2013
Q2 | $115K | Buy |
+2,946
| New | +$115K | 0.03% | 206 |
|